查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基於細胞的檢測市場——行業規模、份額、趨勢、機會、預測、按產品/服務、按應用、按最終用戶、按地區、競爭對手分析 (2018-2028)
市場調查報告書
商品編碼
1244144

全球基於細胞的檢測市場——行業規模、份額、趨勢、機會、預測、按產品/服務、按應用、按最終用戶、按地區、競爭對手分析 (2018-2028)

Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Products & Services, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在預測期內，基於細胞的檢測的全球市場預計將出現令人矚目的增長。

人們對治療慢性病的新藥的需求不斷增長。 在各種疾病爆發中使用治療藥物和增加研究活動是推動全球細胞檢測市場增長的兩個關鍵因素。 政府在醫療保健領域的支出不斷增加以及對藥物毒性篩查的需求不斷增長，預計將推動世界不同地區的市場增長。 此外，對罕見疾病有效治療的需求不斷增長，預計將進一步推動對基於細胞的檢測的需求，加速市場增長到 2028 年。 此外，人們越來越意識到使用新療法的好處以及對降低全球藥物發現相關成本的需求不斷增長，預計將在預測期內進一步支持基於細胞的檢測市場。 例如，2021 年 11 月，Menarini Silicon Biosystems 推出了 CELLSEARCH，這是一種實驗室開發的測試，可幫助使用血液樣本對多發性骨髓瘤細胞進行計數。

對基於細胞的檢測不斷增長的需求推動了市場增長

在預測期內，對藥物開發鑑定和優化程序的需求不斷增長是推動市場發展的主要因素。 越來越多的製藥和生物技術公司採用該技術也是推動該市場增長的關鍵因素。 此外，豬流感和 COVID-19 等疾病爆發的風險增加，以及研究活動比例的增加，預計也將推動多年來的市場增長。 從2020年9月28日至2021年5月22日，美國實驗室檢測的818,939份呼吸道標本中有1,675份（0.2%）在美國檢測出流感病毒呈陽性。 低勞動力和原材料成本以及越來越多的提供藥物發現服務的 CRO 公司預計將在預測期內產生有利可圖的增長。 藥物發現項目的興起和越來越多地採用戰略方法，例如與多家公司合作開發新藥，將進一步推動未來的市場增長。

藥物發現活動的增加推動了市場增長

關節炎、糖尿病、癲癇、癌症和心血管疾病等與生活方式相關的疾病日益流行，這將推動基於細胞的檢測市場的增長。 政府機構正在投資研發部門，用於診斷癌症、糖尿病和自身免疫性疾病等慢性病的新藥開發，預計在預測期內將產生有利可圖的增長。 多年來，全球對治療流行性疾病的新藥需求不斷增長，推動了市場的增長。 例如，2021 年 5 月，美國 FDA 授予 T-Detect COVID-19 常規 T 細胞檢測緊急使用授權 (EUA)。 同樣，在預測期內，越來越多的治療藥物發現調查和市場參與者對 FDA 批准的競爭日益激烈，預計將產生有利的增長。

市場細分

近期發展

  • 例如，2022 年 9 月，弗勞恩霍夫研究所的研究人員開發了 Proxidrugs，它利用基於細胞的廢物處理系統，作為傳染病、癌症和阿爾茨海默病的潛在治療選擇。。
  • 例如，2021 年 11 月，Menarini Silicon Biosystems 推出了 CELLSEARCH，這是一種實驗室開發的測試，可幫助使用血液樣本對多發性骨髓瘤細胞進行計數。
  • 例如，2022 年 8 月，LifeNet Health LifeSciences 宣布將推出一項新的基於細胞的檢測服務，以支持藥物發現開發。

報告範圍

本報告將全球基於細胞的檢測市場分為以下幾類，以及下面詳述的行業趨勢：

基於細胞的檢測市場，按產品/服務分類：

  • 試劑
  • 檢測試劑盒
  • 微孔板
  • 探針和標籤
  • 細胞系
  • 其他

基於細胞的檢測市場，按應用分類：

  • 用於臨床研究
  • 藥物發現和藥物開發
  • 其他

最終用戶基於細胞的檢測市場：

  • 生物技術公司、製藥公司
  • 學術和研究機構等
  • 委託研究機構

按地區劃分的細胞檢測市場：

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋

競爭格局

公司概況：對全球細胞檢測市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第5章臨床試驗分析

  • 正在進行的臨床試驗
  • 已完成臨床試驗
  • 中止的臨床試驗
  • 管道細分（按開發階段）
  • 管道細分（按狀態
  • 管道細分（按研究類型）
  • 按地區劃分的渠道細分
  • 臨床試驗熱圖

第 6 章基於細胞的檢測的全球市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務（試劑、檢測試劑盒、微孔板、探針/標籤、細胞係等）
    • 按應用（臨床研究、藥物開發、其他）
    • 最終用戶（生物技術/製藥公司、學術/研究機構、合同研究機構）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按地區

第 7 章北美基於細胞的分析市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第 8 章歐洲基於細胞的檢測市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 9 章亞太地區基於細胞的檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 10 章南美洲基於細胞的檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 11 章中東和非洲基於細胞的檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品/服務
    • 通過申請
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非基於細胞的檢測
    • 沙特阿拉伯基於細胞的檢測
    • 阿聯酋基於細胞的分析

第 12 章市場動態

  • 司機
  • 做

第13章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第14章競爭格局

  • 業務概覽
  • 提供的產品
  • 最新趨勢
  • 財務信息（公開數據）
  • 管理團隊
  • SWOT 分析
    • Corning, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Lonza Group AG
    • Promega Corporation
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Charles River Laboratories International, Inc.
    • Menarini Silicon Biosystems, Inc.

第15章 戰略建議

簡介目錄
Product Code: 14420

The Global Cell-Based Assays Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for novel drugs for treating chronic diseases. The use of therapeutic drugs during various disease outbreaks, along with the growing number of research activities are two significant factors responsible for the growth of global cell-based assay market. Rising government expenditure in the healthcare sector and the rising need for toxicity screening in drugs are expected to drive market growth across different parts of the globe. Additionally, the growing demand for efficient treatment for rare diseases is further expected to increase the demand for cell-based assays, thereby fuelling market growth through 2028. Besides, growing awareness of the advantages of using new treatments along with the increasing demand to reduce the costs associated with drug discovery across the globe, are further expected to support the cell-based assays market during the forecast period. For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.

Growing Demand for Cell-Based Assays Will Propel the Market Growth

Increasing demand for identification and optimization procedures for drug development is a major factor that will boost market growth during the forecast period. Growing adoption by pharmaceutical and biotechnology firms is another important factor driving the growth of this market. Furthermore, the increasing risk of disease outbreaks like swine flu, and COVID-19 and the growing rate of research activities are also expected to fuel the market growth over the years. From September 28, 2020-May 22, 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for the influenza virus. The low labor and raw material costs along with more and more CRO companies providing drug discovery services are expected to create lucrative growth during the forecast period. Increasing growth in drug discovery projects and rising adoption of strategic approaches, like collaboration with different companies for developing new drugs, will further propel the growth of the market over the years.

Increasing Number of Drug Discovery Activities Will Fuel the Market Growth

The increasing prevalence of lifestyle disorders like arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc., will enhance the growth of the cell-based assay market. Government organizations are investing in the research and development sector for developing new drugs for the diagnosis of chronic diseases such as cancer, diabetes, and autoimmune disorders, which is expected to create lucrative growth during the forecast period. The rising demand for novel drugs across the world for the treatment of pandemic diseases is propelling the growth of the market over the years. For instance, in May 2021, U.S. FDA granted Emergency Use Authorization (EUA) for the T-Detect COVID-19 routine T-cell test. Similarly, the rising number of research for therapeutic drug discovery and growing competition for FDA approvals among the market players is expected to create lucrative growth during the forecast period.

Market Segmentation

The global cell-based assay market can be segmented by products and services, application, end users, and region. Based on products and services, the market can be segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, and Others. Based on application, the market can be segmented into Clinical Research, Drug Discovery & Development, and Others. Based on the end user, the market can be differentiated into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Contract Research Organizations. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global cell-based assays market on account of the growing demand for the identification and optimization of the novel drug in the country.

Market PlayersCorning, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Promega Corporation, F. Hoffmann-La Roche AG, Merck KGaA, Charles River Laboratories International, Inc., Menarini Silicon Biosystems, Inc. are some of the leading players operating in the Global Cell-Based Assays Market.

Recent Development

  • For instance, in September 2022, researchers at the Fraunhofer Institute developed Proxidrugs to utilize a cells-based waste disposal system as a potential therapeutic option for infections, cancer, and Alzheimer's disease.
  • For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.
  • For instance, in August 2022, LifeNet Health LifeSciences announced the launch of its new cell-based assay services to aid in drug discovery and development.

Report Scope:

In this report, Global Cell-Based Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell-Based Assays Market, By Products & Services:

  • Reagents
  • Assay Kits
  • Microplates
  • Probes & Labels
  • Cell Lines
  • Others

Cell-Based Assays Market, By Application:

  • Clinical Research
  • Drug Discovery & Development
  • Others

Cell-Based Assays Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Contract Research Organizations

Cell-Based Assays Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cell-Based Assays Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Cell Based Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others)
    • 6.2.2. By Application (Clinical Research, Drug Discovery & Development, Others)
    • 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Market Map
    • 6.3.1. By Products & Services
    • 6.3.2. By Application
    • 6.3.3. By End User
    • 6.3.4. By Region

7. North America Cell Based Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Cell Based Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Cell Based Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Cell Based Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User

8. Europe Cell Based Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Cell Based Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Cell Based Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Cell Based Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Cell Based Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Cell Based Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Asia-Pacific Cell Based Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Cell Based Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. India Cell Based Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Cell Based Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Cell Based Assays Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Products & Services
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Cell Based Assays Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Products & Services
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By End User

10. South America Cell Based Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Based Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Cell Based Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Cell Based Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Middle East and Africa Cell Based Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Products & Services
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Cell Based Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Products & Services
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Cell Based Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Products & Services
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Cell Based Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Products & Services
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Corning, Inc.
    • 14.6.2. Bio-Rad Laboratories, Inc.
    • 14.6.3. Thermo Fisher Scientific Inc.
    • 14.6.4. Danaher Corporation
    • 14.6.5. Lonza Group AG
    • 14.6.6. Promega Corporation
    • 14.6.7. F. Hoffmann-La Roche AG
    • 14.6.8. Merck KGaA
    • 14.6.9. Charles River Laboratories International, Inc.
    • 14.6.10. Menarini Silicon Biosystems, Inc.

15. Strategic Recommendations